New macrocyclic lathyrane diterpenes, from Euphorbia lagascae, as inhibitors of multidrug resistance of tumour cells

Planta Medica

Volumn 72, Issue 2, 2006, Pages 162-168

  Duarte, Noélia ^a   Gyémánt, Nora ^b   Abreu, Pedro M ^c   Molnár, Joseph ^b   Ferreira, Maria José Umbelino ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b UNIVERSITY OF SZEGED   (Hungary)

^c DEPARTAMENTO DE QUÍMICA   (Portugal)

Author keywords

Diterpenes; Euphorbia lagascae; Lathyrane; Multidrug resistance; P glycoprotein; Phenolic compounds

Indexed keywords

CLEOMISCOSIN A; ENT 16ALPHA,17 DIHYDROXYATISAN 3 ONE; ENT 16ALPHA,17 DIHYDROXYKAURAN 3 ONE; EUPHORBIA EXTRACT; ISOFRAXIDIN; LATHYRANE DITERPENE DERIVATIVE; LATILAGASCENE A; LATILAGASCENE B; LATILAGASCENE C; MACROCYCLIC COMPOUND; PHENOL DERIVATIVE; RHODAMINE 123; SALICYLIC ACID; UNCLASSIFIED DRUG; VANILLIC ACID; VERAPAMIL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; DRUG STRUCTURE; EUPHORBIA; EUPHORBIA LAGASCAE; LYMPHOMA CELL; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEAR OVERHAUSER EFFECT; PROTON NUCLEAR MAGNETIC RESONANCE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; DITERPENES; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; EUPHORBIA; GENES, MDR; HUMANS; LYMPHOMA; MICE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PLANT EXTRACTS; TRANSFECTION;

ANIMALIA; EUPHORBIA; EUPHORBIA LAGASCAE;

EID: 33644534548     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-873196     Document Type: Article

References (27)

1. Grossi A, Biscardi M. Reversal of MDR by verapamil analogues. Hematology 2004; 9: 47-56
2. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002; 2: 48-58
3. Teodori E, Dei S, Scapecchi S, Gualtieri F. The medicinal chemistry of multidrug resistance (MDR) reversing Drugs. Il Farmaco 2002; 57: 385-415
4. Cahoon EB, Ripp KG, Hall SE, McGonigle B. Transgenic production of epoxy fatty acids by expression of a cytochrome P450 enzyme from Euphorbia lagascae seed. Plant Physiol 2002; 128: 615-24
5. Ferrigni NR., McLaughlin JL, Powell RG, Smith CR. Use of potato disc and brine shrimp bioassays to detect activity and isolate piceatannol as the antileukemic principle from the seeds of Euphorbia lagascae. J Nat Prod 1984; 47: 347-52
6. Valente C, Ferreira MJU, Abreu PM, Gyémánt N, Ugocsai K, Hohmann J et al. Pubescenes, jatrophane diterpenes, from Euphorbia pubescens with multidrug resistance reversing activity on mouse lymphoma cells. Planta Med 2004; 70: 81-4
7. Hohmann J, Molnár J, Rédei D, Evanics F, Forgó P, Kálmán A et al. Discovery and biological evaluation of a new family of potent modulators of multidrug resistance: reversal of MDR of mouse lymphoma cells by new natural jatrophane diterpenoids isolated from Euphorbia species. J Med Chem 2002; 45: 2425-31
8. Corea G, Fattorusso E, Lanzotti V, Motti R, Simon PN, Dumontet C et al. Jatrophane diterpenes as modulators of multidrug resistance. Advances of structure-activity relationships and discovery of the potent lead pepluanin A. J Med Chem 2004; 47: 988-92
9. Appendino G, Della Porta C, Conseil G, Sterner O, Mercalli E, Dumontet C et al. A new P-glycoprotein inhibitor from the caper spurge (Euphorbia lathyris). J Nat Prod 2003; 66: 140-2
10. Coenwell MM, Pastan I, Gottesmann MM. Certain calcium channel blockers bind specifically to multidrug-resistance human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem 1987; 262: 2166-70
11. Weaver JL, Szabo G, Pine PS, Gottesman MM, Goldenberg S, Aszalos A. The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multidrug transporter. Int J Cancer 1993; 54: 456-61
12. Kessel D. Exploring multidrug resistance using rhodamine 123. Cancer Commun, 1989: 145-9
13. Lieu LG, Tan RX. New jatrophane diterpenoid esters from Euphorbia turczaninowii. J Nat Prod 2001; 64: 1064-8 and related references cited therein
14. Uemura D, Nakayama Y, Shizuri Y, Hirata Y. The structure of new lathyrane diterpenes, Jolkinols A, B, C and D from Euphorbia jolkini Boiss. Tetrahedron Lett, 1976: 4593-6
15. Seip E, Hecker E. Lathyrane type diterpenoid esters from Euphorbia characias. Phytochemistry 1983; 22: 1791-5
16. Vasas A, Hohmann J, Forgo P, Szabo P. New tri- and tetracyclic diterpenes from Euphorbia villosa. Tetrahedron 2004; 60: 5025-30
17. Lal A, Cambie R, Rutledge P, Woodgate P. Ent-atisane diterpenes from Euphorbia fidjiana. Phytochemistry 1990; 29: 1925-35
18. Gustafson K, Munro M, Blunt J. HIV inhibitory natural products. 3. Diterpenes from Homalanthus acuminatus and Chrysobalanus icaco. Tetrahedron 1991; 47: 4547-54
19. Huang Z, Dostal L, Rosazza J. Mechanisms of ferulic acid conversions to vanillic and guaiacol by Rhodotorula ombra. J Biol Chem 1993; 268: 23954-8
20. Tan J, Bednarek P, Liu J, Schneider B, Svatôs A, Hahlbrock K. Universally occurring phenylpropanoid and species-specific indolic metabolites in infected and uninfected Arabidopsis thaliana roots and leaves. Phytochemistry 2004; 65: 691-9
21. Panichayupakaranant P, Noguchi H, De-Eknamkul W, Sankawa U. Naphthoquinones and coumarins from Impatiens Balsamina root cultures. Phytochemistry 1995; 40: 1141-3
22. Ray A, Chattopadhyay S, Kumar S, Konno C, Kiso Y, Hikino H. Structure of cleomiscosins, coumarinolignoids of Cleome viscosa seeds. Tetrahedron 1985; 41: 209-14
23. Klopman G, Shi LM, Ramu A. Quantitative structure-activity relationship of multidrug resistance reversal agents. Mol Pharmacol 1997; 52: 323-34
24. Seelig A, Landwojtowicz E. Structure-activity relationship of P-glycoprotein substrates and modifiers. Eur J Pharm Sci 2000; 12: 31-40
25. Corea G, Fattorusso E, Lanzotti V, Taglialatela-Scafati O, Appendino G, Ballero M et al. Modified jatrophane diterpenes as modulators of multidrug resistance from Euphorbia dendroides. Bioorg Med Chem 2003; 11: 5221-7
26. Corea G, Fattorusso E, Lanzotti V, Motti R, Simon PN, Dumontet C et al. Structure-activity relationships for Euphocharactins A-L, a new series of jatrophane diterpenes, as inhibitors of cancer cell P-glycoprotein. Planta Med 2004; 70: 657-65
27. Corea G, Fattorusso E, Lanzotti V, Taglialatela-Scafati O, Appendino G, Ballero M et al. Jatrophane diterpenes as P-glycoprotein inhibitors. First insights of structure-activity relationships and discovery of a new, powerful lead. J Med Chem 2003; 46: 3395-402